A Single-Center, Pharmacoepidemiology, Inception Cohort Study Comparing Effectiveness of Allopurinol, Febuxostat and Benzbromarone on Renal Function in Chronic Kidney Disease Patients with Hyperuricemia

Trial Profile

A Single-Center, Pharmacoepidemiology, Inception Cohort Study Comparing Effectiveness of Allopurinol, Febuxostat and Benzbromarone on Renal Function in Chronic Kidney Disease Patients with Hyperuricemia

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Benzbromarone (Primary) ; Febuxostat (Primary) ; Allopurinol
  • Indications Hyperuricaemia; Renal failure
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Dec 2017 New trial record
    • 17 Nov 2017 Results published in the Nephrology Dialysis Transplantation Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top